Literature DB >> 19533171

Survival in non-Hodgkin's lymphoma by histology and family history.

Jianguang Ji1, Asta Försti, Jan Sundquist, Per Lenner, Kari Hemminki.   

Abstract

PURPOSE: Although survival has been studied for various subtypes of non-Hodgkin's lymphoma (NHL), there have been few comprehensive studies to quantify the prognosis, including all specific histologies. The effect of family history on survival in NHL has not been examined.
METHODS: We used the Swedish Family-Cancer Database to estimate hazard ratios in NHL by histology and family history.
RESULTS: Using diffuse centroblastic lymphoma as reference (HR 1.0), patients with Waldenström's macroglobulinemia and hairy-cell leukemia had the best survival. Survival advantage was also noted among patients with lymphoplasmacytic lymphoma and different kinds of follicular lymphomas. For T-cell lymphoma, mycosis fungoides showed a favorable prognosis. As for survival by family history, a total of 98 familial cases were noted in our Database with a similar prognosis compared to sporadic cases in both parental and offspring generations. A non-significant familial concordance of either good or poor survival was noted among family members when probands' prognosis was stratified by survival time.
CONCLUSIONS: Our results provide quantitative prognosis data for patients with NHL according to specific histologies. Patients with a familial NHL had a similar prognosis compared to patients with sporadic disease. The data suggest familial concordance in either good or poor survival among family members.

Entities:  

Mesh:

Year:  2009        PMID: 19533171     DOI: 10.1007/s00432-009-0618-0

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  30 in total

Review 1.  Waldenström's macroglobulinemia: clinical features, complications, and management.

Authors:  M A Dimopoulos; P Panayiotidis; L A Moulopoulos; P Sfikakis; M Dalakas
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

2.  Increasing incidence of non-Hodgkin's lymphoma in Canada, 1970-1996: age-period-cohort analysis.

Authors:  Shiliang Liu; Robert Semenciw; Yang Mao
Journal:  Hematol Oncol       Date:  2003-06       Impact factor: 5.271

3.  Survival in breast cancer is familial.

Authors:  Kari Hemminki; Jianguang Ji; Asta Försti; Jan Sundquist; Per Lenner
Journal:  Breast Cancer Res Treat       Date:  2007-08-03       Impact factor: 4.872

Review 4.  What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice?

Authors:  H Lango; M N Weedon
Journal:  J Intern Med       Date:  2008-01       Impact factor: 8.989

5.  Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database.

Authors:  Andrea Altieri; Justo Lorenzo Bermejo; Kari Hemminki
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

6.  The nation-wide Swedish family-cancer database--updated structure and familial rates.

Authors:  K Hemminki; X Li; K Plna; C Granström; P Vaittinen
Journal:  Acta Oncol       Date:  2001       Impact factor: 4.089

Review 7.  Etiologic impact of known cancer susceptibility genes.

Authors:  Kari Hemminki; Asta Försti; Justo Lorenzo Bermejo
Journal:  Mutat Res       Date:  2007-08-01       Impact factor: 2.433

8.  The updated Swedish family-cancer database used to assess familial risks of prostate cancer during rapidly increasing incidence.

Authors:  Kari Hemminki; Charlotta Granström; Jan Sundquist; Justo Lorenzo Bermejo
Journal:  Hered Cancer Clin Pract       Date:  2006-12-15       Impact factor: 2.857

Review 9.  Treatment of hairy-cell leukemia: current views.

Authors:  M S Tallman; L C Peterson; D Hakimian; S Gillis; A Polliack
Journal:  Semin Hematol       Date:  1999-04       Impact factor: 3.851

Review 10.  Mantle-cell lymphoma.

Authors:  E Campo; M Raffeld; E S Jaffe
Journal:  Semin Hematol       Date:  1999-04       Impact factor: 3.851

View more
  5 in total

Review 1.  Host genetics in follicular lymphoma.

Authors:  James R Cerhan
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-05       Impact factor: 3.020

2.  Population-based study on the impact of the familial form of Waldenström macroglobulinemia on overall survival.

Authors:  Vilhjálmur Steingrímsson; Sigrún Helga Lund; Ingemar Turesson; Lynn R Goldin; Magnus Björkholm; Ola Landgren; Sigurdur Y Kristinsson
Journal:  Blood       Date:  2015-03-26       Impact factor: 22.113

3.  A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the "REal world dAta in LYmphoma and survival in adults" (REALYSA) cohort.

Authors:  Hervé Ghesquières; Cédric Rossi; Fanny Cherblanc; Sandra Le Guyader-Peyrou; Fontanet Bijou; Pierre Sujobert; Pascale Fabbro-Peray; Adeline Bernier; Aurélien Belot; Loic Chartier; Luc-Matthieu Fornecker; Isabelle Baldi; Krimo Bouabdallah; Camille Laurent; Lucie Oberic; Nadine Morineau; Steven Le Gouill; Franck Morschhauser; Corinne Haioun; Gandhi Damaj; Stéphanie Guidez; Gaëlle Labouré; Olivier Fitoussi; Laure Lebras; Rémy Gressin; Gilles Salles; Loïc Ysebaert; Alain Monnereau
Journal:  BMC Public Health       Date:  2021-03-02       Impact factor: 3.295

4.  Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico.

Authors:  Eleazar Hernandez-Ruiz; Martha Alvarado-Ibarra; Lourdes Esthela Juan Lien-Chang; Luisa Banda-Garcia; Jorge Luis Aquino-Salgado; Gabriel Barragan-Ibanez; Eva Fabiola Ramirez-Romero; Cesar Nolasco-Cancino; Wilfrido Herrera-Olivares; Javier de Jesus Morales-Adrian; Eugenia Patricia Paredes-Lozano; Maria Eugenia Espitia-Rios; Maria de Monserrat Gonzalez Lopez-Elizalde; Jose Luis Lopez-Arroyo; Jorge Enrique Trejo-Gomora; Jose Antonio De la Pena-Celaya; Jose Luis Alvarez-Vera; Luara Luz Arana-Luna; Annel Martinez-Rios; Rodrigo Resendiz-Olea; Lucero Jazmin Rodriguez-Velasquez; Nidia Zapata-Canto; Juan Manuel Perez-Zuniga
Journal:  World J Oncol       Date:  2021-02-24

5.  Concordance in survival among first-degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia.

Authors:  Fredrik Baecklund; Sara Ekberg; Richard Rosenquist; Johan Askling; Sandra Eloranta; Karin E Smedby
Journal:  Eur J Haematol       Date:  2020-09-29       Impact factor: 2.997

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.